Shandong Sanyuan Biotechnology Co.Ltd. (301206) — Cash Flow Quality Index
Shandong Sanyuan Biotechnology Co.Ltd. (301206) has a Cash Flow Quality Index of 2.50x as of September 2025. Operating cash flow of CN¥24.79 Million exceeds net income of CN¥9.92 Million, indicating high earnings quality where cash backs reported profits. Also explore how large is Shandong Sanyuan Biotechnology Co.Ltd.'s balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shandong Sanyuan Biotechnology Co.Ltd. Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Shandong Sanyuan Biotechnology Co.Ltd. across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 301206 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Shandong Sanyuan Biotechnology Co.Ltd. (2013–2024)
Year-by-year earnings quality comparison for Shandong Sanyuan Biotechnology Co.Ltd.. For live market cap and the full company financial profile, see 301206 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.13x | CN¥-13.65 Million | CN¥104.95 Million | ▼ -113.4% |
| 2023 | 0.97x | CN¥57.31 Million | CN¥58.87 Million | ▲ +89.1% |
| 2022 | 0.51x | CN¥84.26 Million | CN¥163.69 Million | ▼ -57.1% |
| 2021 | 1.20x | CN¥642.08 Million | CN¥535.42 Million | ▲ +28.3% |
| 2020 | 0.93x | CN¥217.37 Million | CN¥232.57 Million | ▼ -14.6% |
| 2019 | 1.09x | CN¥149.21 Million | CN¥136.31 Million | ▲ +13.9% |
| 2018 | 0.96x | CN¥65.46 Million | CN¥68.09 Million | ▼ -11.2% |
| 2017 | 1.08x | CN¥20.25 Million | CN¥18.70 Million | ▼ -34.3% |
| 2016 | 1.65x | CN¥22.96 Million | CN¥13.94 Million | ▼ -64.7% |
| 2015 | 4.66x | CN¥9.50 Million | CN¥2.04 Million | ▼ -24.7% |
| 2014 | 6.19x | CN¥3.20 Million | CN¥516.06K | ▼ -43.5% |
| 2013 | 10.96x | CN¥3.89 Million | CN¥354.81K | — |